Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled budesonide for prevention of bronchopulmonary dysplasia in very preterm infants
NL-OMON29190Phase 3Recruiting
- Sponsor
- Erasmus MC
- Start
- Mar 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in bronchopulmonary dysplasia (BPD) comparing Budesonide with Placebo (2 arms). Started Mar 2013; status: recruiting.
02
Drugs
budesonide
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NL-OMON29190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29190.